Medical Health Cluster


Growing Evidence Supports Repurposing Antidepressants to Treat COVID-19

Mounting evidence suggests selective serotonin reuptake inhibitors (SSRI) are associated with lower COVID-19 severity. A large analysis of health records shows patients with COVID-19 taking an SSRI were significantly less likely to die of COVID-19 than a matched control group. “We can’t tell if the drugs are causing these effects, […]

Read More